IndraLab
Statements
sparser
"Moreover, no significant difference in the anti-tumor effects of ML364 & PD-1 mAb combination therapy was observed between the sg Control and sg Cd47 groups, suggesting that, in the mouse lung cancer model, the anti-tumor effect of ML364 combined with PD-1 mAb is primarily driven by the USP2-CD47 axis (Fig. xref )."
sparser
"The GST pull-down assay showed that CD47-Δ3 with missing amino acid residues from 290 to 323, but not the CD47-Δ1 lacking the residues of 163–176 and Δ2 deleting residues of 229–235 in the cytoplasmic region, failed to interact with USP2 in cells, suggesting that CD47 interacts with USP2 largely through its C-terminal cytoplasmic region (Fig. xref )."